Maximizing the Quality and Reporting Standards of Autism Intervention Science.
Shannon LaPoint, Claire Brito Klein, Micheal Sandbank, Kristen Bottema-Beutel, Sue Fletcher-Watson, Gauri Divan, Dagmara Dimitriou, Evdokia Anagnostou, Mette Elmose Andersen, Amanda Binns, Tony Charman, Jasper A Estabillo, Stephanie M Fecteau, Anna Ferrari, Marie-Maude Geoffray, Lauren H Hampton, Sabri Hergüner, Emily S Kuschner, Jia Ying Sarah Lee, Julie Segers, Deanna Swain, Sarah Vejnoska, Giacomo Vivanti, Chongying Wang, Jonathan Green
PMID 41070555WHAT IT FOUND
This paper proposes stricter reporting standards for autism intervention trials, such as mandatory pre-registration and CONSORT checklists.
It argues that current poor reporting inflates apparent treatment effects but presents no new clinical data or outcomes.
What this paper is
This is a commentary proposing new reporting standards for autism intervention trials. It summarizes existing concerns about bias and poor reporting but presents no new patient data, outcomes, or intervention effects. There is no finding here to act on clinically.
Declared interests
The authors are prominent researchers and editors in the field with various financial ties to intervention training, book royalties, consulting, and funding bodies like the NICHD and NIH. Several authors have direct conflicts of interest related to the interventions being critiqued.
The easy way to misread this
Do not treat this as evidence that specific autism therapies are ineffective. The paper argues that the quality of existing trial evidence is often inflated by poor reporting, but it does not test or report on the efficacy of any treatment itself.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →